Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer

The EphA2 receptor tyrosine kinase is overexpressed in a variety of human epithelial cancers and is a determinant of malignant cellular behavior in pancreatic adenocarcinoma cells. Moreover, it is expressed in tumor endothelium and its activation promotes angiogenesis. To better clarify the therapeu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ansuini, Helenia, Meola, Annalisa, Gunes, Zeynep, Paradisi, Valentina, Pezzanera, Monica, Acali, Stefano, Santini, Claudia, Luzzago, Alessandra, Mori, Federica, Lazzaro, Domenico, Ciliberto, Gennaro, Nicosia, Alfredo, La Monica, Nicola, Vitelli, Alessandra
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2814375/
https://ncbi.nlm.nih.gov/pubmed/20130824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/951917
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados